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Abstract
Background: The morning hours are associated with increased cardiovascular (CV) risk, and vascular endothelial
function (VEF) is a strong predictor of CV disease. A diurnal rhythm in VEF has been established but the morning
variation in VEF is not well-documented. Thus, we tested if VEF is impaired across the vulnerable morning period.
Methods: After overnight fasts, eight healthy men (age 26.3 ± 3 yr) underwent assessments of VEF under
standardized testing conditions every 2 h from 0700 to 1300 h on two separate days. VEF was estimated following
5 min brachial artery occlusions by hyperemic flow-mediated dilation (FMD).
Results: There was no significant change in FMD or hyperemic shear stimulus across the 6 h vulnerable period on
either day, despite changes in physical activity and meals across these periods.
Conclusion: In this healthy group of young men, VEF is stable across the vulnerable morning period when typical
behaviors occurred (breakfast and physical activity). Future research should focus on the roles of sleep, physical
inactivity during sleep and endogenous circadian rhythm in VEF.
Keywords: Morning cardiovascular vulnerability, Adverse cardiac events, Flow mediated dilation, Endothelial
function, Sleep inertia
Background
Adverse cardiovascular (CV) events including myocar-
dial infarction, ventricular arrhythmias and sudden car-
diac death occur more frequently early in the morning,
especially within 3 h of awakening [1, 2]. It can be ar-
gued that these events could be triggered by the stress of
awakening from sleep or the initiation of active behav-
iors across the morning [3] especially in people with
established CV risk. In addition, many traditional CV
risk markers such as activity-related surges in BP [4], in-
creased pro-thrombotic plasminogen activator inhibitor
1 (PAI-1) [5], cardio-vagal withdrawal [6] and increased
alpha-sympathetic drive [6, 7] occur early in the morn-
ing and could contribute to this epidemiological finding.
Endothelial function is an important predictor of CV
disease [8, 9], and changes in endothelial function can
be detected before structural adaptations in the vascula-
ture are detectable by angiography or ultrasound [10].
Endothelial function can be measured as flow mediated
dilation (FMD) of the brachial artery during induced
hyperemia following release of blood flow occlusion [11].
During FMD measurement, increased blood flow triggers
release of nitric oxide (NO) from the vascular endothe-
lium resulting in dilation of the conduit artery [12, 13].
Brachial artery and coronary artery endothelial function
are strongly correlated [14] and reduced FMD is a surro-
gate marker of reduced NO bioavailability and an early
hallmark of atherosclerosis [15]. FMD is sensitive to fac-
tors including, but not limited to sleep [16], meals, and
physical activity [17]. Finally, FMD has been found to ex-
hibit a clear diurnal rhythm with impaired function in the
early morning hours [18–25].
Due to its diurnal variation, it has been speculated that
lower endothelial function may play a role in the time of
adverse CV events [21]. Although numerous studies
have documented differences in FMD at various times of
the day, to our knowledge, no studies have specifically
focused on measuring endothelial function over the
period of greatest CV vulnerability (0700–1300 h) while
participants perform their normal routine behaviors
such as physical activity and eating breakfast. We
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previously found that FMD does not change between
0800 and 1000 h in healthy individuals while under stan-
dardized testing conditions [26]. The goal of the current
study was to extend these observations to test if endo-
thelial function is stable for the entire vulnerable morn-
ing period (0700–1300 h) in ostensibly healthy
individuals while performing standard behaviors such as
eating and physical activity.
Methods
Study design (Fig. 1)
This study consisted of two screening visits and two
experimental visits involving measurement of brachial
artery FMD over the course of 6 h on consecutive days
as subjects performed their normal daily activities. All
procedures for the study were approved by local Institu-
tional Review Board, and the participants gave written
informed consent for their participation.
Participants and screening
Based on self-report, participants were: 1) non-smokers
and not using any form of tobacco, 2) free of cardiovas-
cular disease or diabetes, 3) not taking any vasoactive
medications or vitamin supplements, and 4) recreation-
ally active (>90 min per week of physical activity, includ-
ing walking and structured exercise sessions).
Screening visits: At the first visit all experimental pro-
cedures were explained to the participants and they were
familiarized with the laboratory setting and they pro-
vided their written consent. Thereafter, height, weight,
and blood pressure were measured using standard pro-
cedures, and a medical health history and a question-
naire regarding behavioral habits was completed to
screen for any preexisting medical conditions and to de-
termine habitual physical activity levels. Body mass
index (BMI) was calculated as kg∙m−2. All participants
were normotensive (<140/90 mmHg).
Testing trials
Testing was conducted on two consecutive days. Proce-
dures were identical on both days. Participants were told
to not perform any exercise beyond walking for 24 h
prior to the trials. Participants wore a fitted Omron HJ-
720ITC pedometer [27] immediately upon awakening
and throughout the entire testing period each day. Par-
ticipants arrived at approximately 0630 h at the labora-
tory after an overnight fast of at least 6 h. Participants
were encouraged to slowly walk for approximately 5 min
(not more than 10 min) enroute to the laboratory so that
the FMD measurement would not be confounded by
previous prolonged physical inactivity e.g., during the
sleep period [28]. After 20 min of supine rest before
each measurement, brachial artery FMD was measured
at 0700, 0900, 1100, and 1300 h. On both testing days,
subjects were fed a standardized low-fat meal consisting
of 58 g of Kellogg’s Frosted Flakes®, and 240 mL of skim
milk (380 kcal, 76 g carbohydrate, 0 g fat, 18 g protein,
42 g sugar) at 0800 h. A standard low fat breakfast has
been shown to not affect brachial artery FMD measure-
ments [29]. Participants were allowed to move freely be-
tween measurements on the first day, and on the second
day they were told to match the steps accumulated on
the first day such that the cumulative steps for each se-
quential measurement interval were similar on each of
the two measurement days.
Brachial artery flow mediated dilation
Brachial artery FMD was measured according to
current guidelines as previously performed in our la-
boratory [30, 31]. Each measurement was performed in
a quiet and climate controlled (22–25 °C) room. An
automatic blood pressure cuff (E-20 rapid cuff inflator;
D.E. Hokanson, Bellevue, Wash., USA) was placed on
the right forearm. Images of the brachial artery were
obtained with a 2-D high-resolution ultrasound system
(Terason t3000, Teratech Corp., Burlington, Mass.,
USA) using a 5- to 12-MHz multi-frequency linear-
array transducer. Once satisfactory images of near and
far arterial walls were obtained, the transducer was se-
cured and stabilized in a stereotactic clamp and land-
marks were made on the participant’s skin to ensure
similar placement of the transducer for subsequent as-
sessments. In addition to imaging the arterial dimen-
sions, Doppler ultrasound was used to concurrently
measure brachial artery blood velocity. Doppler flow
signals were corrected to an insonation angle of 60°
Fig. 1 Study design
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and the sample volume was placed in the middle of the
artery. Vessel images and Doppler measurements of
blood velocity were continuously recorded for 1 min at
baseline prior to cuff inflation. The automatic blood
pressure cuff was then rapidly inflated to 250 mmHg
and this pressure was maintained for 5 min. Diameter
and blood velocity recordings resumed 30 s prior to
cuff deflation and continued for 3 min after deflation.
Ultrasound images were continuously recorded at 5
frames · s−1 with Camtasia (TechSmith, Okemos, Mich.,
USA), and stored as .avi files [32]. This same procedure
was repeated at each measurement interval.
Arterial diameters and blood velocities: Off-line
analyses of arterial diameters were performed using au-
tomated edge-detection software (Brachial Analyzer,
Medical Imaging Applications LLC, Coralville, IA,
USA) as previously described [33]. This software en-
ables determination of a region of interest in which the
near and far vessel walls are clearest. The vessel wall
borders are then detected using an optimal graph
search-based segmentation that uses a combination of
pixel density and image gradient as an objective func-
tion. All analyzed images were reviewed by an investi-
gator and edited as needed to ensure that diameter
measures were determined from the intima-lumen
interface at the near and far vessel wall. Blood velocities
were determined using custom written software select-
ing a region of interest that surrounded the Doppler
wave [32]. The velocity–time integral was used to cal-
culate the mean blood velocity. The peak dilation after
cuff deflation was determined as the highest 3 s moving
average and recorded as a percentage change from
baseline diameter (FMD %). Shear rate was calculated
as the area under the curve from the time of deflation
up until peak diameter (SRauc). For consistency, all
measurements were performed by the same investigator
(SST) who was blinded to the participant identity and
time code of each image file.
Statistical analysis
Descriptive statistics were used to summarize subject
characteristics. Repeated measures ANOVAs were con-
ducted to test for differences in baseline diameter (BD)
and SRauc across time. A mixed model ANOVA was
then conducted on FMD as the dependent variable with
time and day as a fixed factor, and step count and BD as
covariates. Finally, bivariate correlations were tested be-
tween FMD and step count between FMD measure-
ments. All values are expressed as the mean ± SD unless
otherwise specified. The a priori alpha level for statis-
tical significance was set at 0.05. To better understand
the uncertainty in measurements of BD and FMD, we
also estimated variance components associated with sub-
ject, experimental replication (i.e., day), and time.
Results
We recruited and tested eight subjects who comprised a
homogenous group of ostensibly healthy, active young
men (Table 1). All results are presented in Fig. 2.
Baseline diameter (BD): There was no significant dif-
ference in BD between days (F1,49 < 0.19, p = 0.66) and
across time (F3,49 = 1.57, p = 0.16), and no interaction be-
tween day and time (p = 0.79).
SRauc: There was no significant difference in SRauc
between days (F1,26 = 3.90, p = 0.06) and across time
(F3,26 = 0.16, p = 0.92), and no interaction between day
and time (p = 0.88).
FMD: There was no significant difference in FMD be-
tween days (F1,45 = 3.4, p = 0.07) and across time (F3,45 =
0.19, p = 0.90), and no interaction between day and time
(p = 0.85) even while controlling for BD and inter subject
variability.
Activity: There was no significant difference in step
counts between days (F1,52 = 0.16, p = 0.69). There was
a systematic difference in step counts across the morn-
ing (F3,52 = 57.81, p < 0.0001), and this pattern was
similar on both days (and no interaction between day
and time (p = 0.99)). There was no significant correl-
ation between FMD and step count across the morning
period (r = −0.1597, p = 0.23).
To better understand the uncertainty in measurements
of BD and FMD, we estimated variance components as-
sociated with subject, day and time. In this model there
is only a single overall mean response, either for BD or
FMD, with individual observations resulting from (ran-
dom) perturbations from the mean according to the
subject, the day, or time within a day (Table 2). The
magnitude of the standard deviations and their confi-
dence intervals are comparable to previously published
reports involving interventions using low intensity
physical activity [32] and vitamin C [34] over time in a
single day.
Discussion
The goal of this study was to test if FMD is stable during
across the morning hours which are associated with in-
creased incidence of adverse CV events even in osten-
sibly healthy individuals [1]. Thus, in this pilot study, as
the first step towards understanding the contribution of
Table 1 Subject demographics
Variable Value
N 8
Age (yrs.) 26.3 ± 3
BMI (kg.m2) 22.49 ± 1.7
Systolic blood pressure (mm Hg) 114 ± 6
Diastolic blood pressure (mm Hg) 76 ± 6
Data are presented as mean ± SD
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Fig. 2 Graphical representation of a FMD, b Baseline diameter, c Hyperemic shear and d Physical activity at each measurement on both days.
Gray bars represent Day 1, Black bars represent Day 2. Error bars represent standard error
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endothelial function to adverse CV events, before study-
ing participants with increased CV risk, we chose to
study healthy individuals. Baseline measurements were
made after at least 6 h of overnight fasting, and there-
after across the measurement period participants ate a
standardized breakfast and performed light intensity
physical activity (walking) to simulate a natural daily
activity and food pattern. Under these conditions, we
discovered that FMD is stable during the morning
period in this group of healthy men. Our findings ex-
tend our previous finding that FMD was stable across
the 0800–1000 h period [26]. Our findings support pre-
vious findings by Kawano et al. [19] who reported that
FMD is quite stable across the morning despite strictly
controlled posture between measurements. Bau et al. [35]
also found little change in FMD across the morning but
they do not report the amount of activity or meal compos-
ition between measurements. Bau and colleagues [35] did
find that brachial artery baseline diameter was lowest at
0700 h compared to afternoon measurements. We did not
find any significant difference in our baseline diameters
between 0700 and 1300 h. Assuming that increased alpha
sympathetic activity increases across this same morning
period [7] our finding would suggest that alpha sympa-
thetic activity does not affect brachial artery baseline di-
ameters in our group. Because we tested participants on
two separate days and found the same result our study
also establishes reproducibility within our measurements
and strengthens the argument that in young healthy men
performing normal daily activities, FMD is largely stable
during the morning hours.
Our findings are discordant with the findings of Otto
and colleagues [18] who discovered that endothelial
function was significantly higher at 11 AM as compared
to 6 AM. In their well-controlled study, they measured
FMD before sleep, immediately upon awakening and 5 h
after awakening. A main difference between our studies
is that in Otto el al’s. participants were awakened at
0600 h whereas our participants woke on their own vol-
ition and travelled to the laboratory, such that we had
no measurements immediately following sleep. It is in-
teresting to note that Otto et al’s mean FMD values at
2100 h and at 1100 h are approximately 7.5 % and our
mean FMD across all time points is very similar 6.9 %.
Therefore, the fact that Otto and colleagues found FMD
immediately at awakening to be greatly diminished
(4.4 %) strongly suggests that the effect of sleep and/or
the physical inactivity that accompanies sleep [28] re-
duces endothelial function across the night and that this
persists immediately upon awakening, akin to a sleep in-
ertia [16] of vascular function. However, FMD appears
to quickly improve within about 2 h of awakening. There
is also a possibility of an endogenous circadian rhythm
in FMD causing FMD to increase in the 2 h period
following waking. It is thus essential to separate out the
effects of sleep, physical inactivity and endogenous circa-
dian rhythm in FMD to truly understand the predictive
value of FMD in morning CV events.
Our study adds to the current body of knowledge in
other important ways. For instance, we also measured
the hyperemic stimulus after cuff release (SRauc) which
has been shown to influence FMD and which is also a
measure of microvascular function [36]. Previously, it
was unknown if SRauc changes and/or affects FMD
measurements during the early morning hours. Our
study suggests that in healthy young men SRauc is
largely stable across the morning hours. Our study is also
important for scientists who study the effects of high fat
or high sugar meals on endothelial function [17]. Most of
these studies are conducted in a fasting state in the morn-
ing and it is sometimes difficult to differentiate the effects
of high fat/sugar meals versus the plain effect of time.
From our study, it is clear that in this population, any
changes in FMD due to a high fat/sugar meal, are likely to
be due to the experiment and not time into the protocol.
Mechanisms: There are various mechanisms which
may affect endothelial function in the early morning
hours, and which may play a role in adverse CV events
in the morning. For instance, it is known that plasmino-
gen activator inhibitor −1, which adversely affects endo-
thelial function has a diurnal and a circadian rhythm
that peaks in the morning [5, 37]. In addition, there is
an increase in sympathetic tone in the early morning
hours [7] which may adversely affect endothelial func-
tion [38]. However, our data suggest that the cumulative
effect of various mechanistic variables is largely constant
in the early morning hours, in young healthy individuals.
Limitations
We did not keep physical activity constant between mea-
surements on each trial day, which is a concern because
minimal intensity physical activity affects FMD [32].
However, we had participants control their activity levels
on Day 2 to match those on Day 1. And since there were
changes in activity across the day on each day, but no
changes in FMD, it seems likely that there was an in-
crease in VEF between awakening and our first measure-
ment time which was associated with the lowest level of
Table 2 Variability in SD of BD and FMD stemming from
subjects, measurements between days and measurements
across time
Source of variability Baseline diameter
(mm) SD (95 % CI)
FMD% SD (95 % CI)
Subject 0.271 (0.153, 0.479) 2.20 (1.03, 4.70)
Day 0.091 (0.023, 0.398) 2.16 (1.06, 4.42)
Time 0.174 (0.124, 0.244) 2.75 (2.00, 3.80)
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accumulated steps (Fig. 2), which would mean that even
a minimal level of activity may be sufficient to increase
endothelial function in the morning. Second, our study
may be limited because of relatively small sample size.
However, this limitation is partly compensated for by re-
peating all measurements in each participant on two
separate days. Ours was an initial pilot study and future
research using larger sample sizes including different
population groups is necessary before generalizing our
findings. We have also provided the reader the variability
and confidence intervals in our data (Table 2). The mag-
nitude of the standard deviations and their confidence
intervals are comparable to previously published reports
involving interventions using low intensity physical ac-
tivity [32] and vitamin C [34] over time in a single day.
Third, we did not study biomarkers, heart rate, blood
pressure and smooth muscle dilation. This was an initial
study to test if FMD is stable across the vulnerable
morning period. Whereas biomarkers and other physio-
logical measurements will have allowed us to see if the
mechanisms controlling, we also found that FMD is
largely stable across the morning. Finally, we did not
control the amount of participants’ sleep. Participants
were informed that they should sleep for 8 h and awaken
at the same times for both trials, but sleep was not mon-
itored. It is possible that differences in sleep time and
quality may have different effects on FMD. Conversely,
sleeping in a laboratory may have adversely affected
sleep and interfered with the validity of measurements.
Conclusion
In healthy young men, vascular endothelial function is
stable during the morning between of 0700 and 1300 h,
but our results need validation using large sample sizes
before they can be generalized. In addition future studies
should separately evaluate the effects of physical inactiv-
ity, prolonged sleep and endogenous circadian system on
endothelial function in the morning, in healthy people
and those with chronic diseases including CV disease.
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